Activating Compound | Comment | Organism | Structure |
---|---|---|---|
(D-Ala2, methyl-Phe4, Glyol5)enkephalin | treatment of cells co-expressing isoform PLD2 and my-opioid receptor MOR1 leads to increase in PLD2 activity and an induction of receptor endocytosis | Homo sapiens | |
my-opioid receptor variant MOR1D | activation of isoform PLD2 | Homo sapiens |
Cloned (Comment) | Organism |
---|---|
expression in HEK-293 cell | Homo sapiens |
Protein Variants | Comment | Organism |
---|---|---|
K758R | catalytically inactive. Inhibition of enzyme activity by overexpression of the mutant blocks the constitutive isoform PLD2 activation and impairs the endocytosis of my-opioid receptors MOR1D | Homo sapiens |
Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
additional information | Homo sapiens | endocytotic trafficking of my-opioid receptor MOR1, delta-opioid receptor DOR and cannabinoid receptor isoform CB1 are mediated by an isoform PLD2 dependent pathway | ? | - |
? |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | - |
isoform PLD2 | - |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
HEK-293 cell | - |
Homo sapiens | - |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
additional information | endocytotic trafficking of my-opioid receptor MOR1, delta-opioid receptor DOR and cannabinoid receptor isoform CB1 are mediated by an isoform PLD2 dependent pathway | Homo sapiens | ? | - |
? |